Mattias Bergqvist

5PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Vasu R Sah, Henrik Jespersen, Joakim Karlsson

|Apr 11, 2023
Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospective study.

Ebba Asplund, Mattias Bergqvist, Maura Krook

|Mar 22, 2022
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.

Jairam Krishnamurthy, Jingqin Luo, Rama Suresh

|Sep 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial.

Costanza Paoletti, William E Barlow, Erin F Cobain

Pageof 1

Frequent Collaborators

2 joint publications

Hildur Helgadottir

1 joint publications

Costanza Paoletti

1 joint publications

Erin F Cobain

1 joint publications

Julie R Gralow